HOHirokazu Oguni

Hirokazu Oguni

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hirokazu Oguni has a total of 126 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Nationwide survey of glucose transporter-1 deficiency syndrome (GLUT-1DS) in Japan

    by Yasushi Ito, Satoru Takahashi, Kuriko Kagitani-Shimono, Jun Natsume, Keiko Yanagihara, Tatsuya Fujii, Hirokazu Oguni


  • Ketogenic diet therapy can improve ACTH-resistant West syndrome in Japan

    by Yoshiko Hirano, Hirokazu Oguni, Mutuko Shiota, Aiko Nishikawa, Makiko Osawa


  • Epilepsy and Intellectual and Developmental Disabilities

    by Hirokazu Oguni

    The co‐occurrence of epilepsy in people with intellectual disabilities (ID) and other developmental disabilities (DD) has received attention because it has a significant negative impact on health, well‐being, and quality of life. The current research investigating the frequency and form of epilepsy in children with ID and DD is reviewed, with particular attention is paid to children presenting with coexisting autism spectrum disorder (ASD) and attention deficit hyperactivity disorder (ADHD). Complications in assessment and treatment arising from comorbidities are considered. The most recent and epidemiological survey of children with epilepsy demonstrates that approximately one‐fourth of patients with childhood epilepsy had ID. The prevalence of DD (including ADHD and ASD) in children with epilepsy ranges from 7.1% to 32%, which exceeds that of the general population. Multiple studies have suggested that ADHD in children with epilepsy is largely comorbid rather than cause and effect because it is already present before the onset of epilepsy in 80% of these children. However, the co‐occurrence of epilepsy and ASDs is frequent in people with known organic brain disorders, in which several causal relationships have been speculated. Recent studies have shown that the severity of ID is an important factor in determining the incidence of epilepsy complications in those with ASD, and also the incidence of ASD complications in those with epilepsy. The co‐occurrence of epilepsy, ID, and DD appears common. ID might play a key role in increasing the burden of epilepsy, as well as DD comorbidity. The comorbidity of ID and DD in patients with epilepsy might reduce the seizure threshold, resulting in an increase in the frequency of seizures as well as epileptiform electroencephalographic abnormalities, although evidence is limited and further investigations are warranted.


  • Open Access

    Clinical analysis of catastrophic epilepsy in infancy and early childhood: Results of the Far-East Asia Catastrophic Epilepsy (FACE) study group

    by Hirokazu Oguni, Taisuke Otsuki, Katsuhiro Kobayashi, Yushi Inoue, Eiji Watanabe, Kenji Sugai, Akio Takahashi, Shinichi Hirose, Shigeki Kameyama, Hitoshi Yamamoto, et al.


  • A long-term, clinical study on symptomatic infantile spasms with focal features

    by Akiko Fujii, Hirokazu Oguni, Yoshiko Hirano, Mutsuki Shioda, Makiko Osawa


    • 1 May 2012
      • Vol. 44  (3) , 244-8

    [A child with paroxysmal exertion-induced dyskinesia].

    by Takatoshi Sato, Yasushi Ito, Hirokazu Oguni, Kaoru Eto, Akiko Fujii, Makiko Osawa

    We experienced a 12-year-old boy with paroxysmal exertion (exercise)-induced dyskinesia (PED). His attacks, characterized by painless paralytic stiffness of the extremities during running or playing, developed at 4 years of age. He was initially diagnosed as having epilepsy based on epileptic discharges on interictal EEG. Although several anti-epileptic drugs were not effective, clorazepate was found to be very useful for complete control of attacks for 3 years. His attacks recurred at 8 years of age and appeared to be aggravated by psychological stress, fatigue and lack of sleep. His attacks were confirmed to be non-epileptic paroxysmal hypokinesia with rigid tetraplegia, by ictal video EEG recording, and he was diagnosed as having PED. They did not respond to various anti-epileptic drugs and L-dopa/carbidopa. His attacks were reduced to some extent by administration of hydroxyzine. PED is a very rare condition and similar to paroxysmal kinesigenic dyskinesia (PKD). There is a strong possibility that patients with PED have been misdiagnosed as PKD.


    • 1 September 2011
      • Vol. 43  (5) , 373-7

    [Three children with Rasmussen encephalitis showing marked improvement in daily life activity following the functional hemispherectomy].

    by Mutsuki Shioda, Hirokazu Oguni, Yasushi Ito, Taku Ochiai, Tomokatsu Hori, Ayako Muto, Satornu Takahashi, Akie Miyamoto, Hitoshi Osaka, Makiko Osawa

    We investigated seizure, intelligence quotient (IQ), and neurological outcomes including the process of motor function recovery after functional right hemispherectomy in 3 children with Rasmussen's encephalitis (RE). Before the procedure, they were unable to walk, nor sit without support due to progressive worsening of left hemiplegia and relentless epilepsia partialis continua (EPC) of the left extremities, which were refractory to antiepileptic drug and immunological treatment. After functional right hemispherectomy, EPC completely disappeared, although complete left hemiplegia was sustained. However, they recovered up to being able to walk independently with assistance devices, and to have an ordinary life with family support within 1.5 to 5 months through rehabilitation. At the same time, the interictal EEG improved on the unaffected side of hemisphere, exhibiting a posterior alpha rhythm. Their IQ also improved, and they were able to attend school. Early functional hemispherectomy should be considered before patients with RE are left in a serious condition due to progressive worsening of hemiplegia and seizures refractory to the available treatment.


  • Open Access

    Retrospective multiinstitutional study of the prevalence of early death in Dravet syndrome

    by Masako Sakauchi, Hirokazu Oguni, Ikuko Kato, Makiko Osawa, Shinichi Hirose, Sunao Kaneko, Yukitoshi Takahashi, Rumiko Takayama, Tateki Fujiwara

    Purpose: A questionnaire survey was conducted in Japan to investigate the causes and prevalence of death related to Dravet syndrome. Methods: A questionnaire was delivered to 246 hospitals at which physicians were treating childhood epilepsy to gain information about the total number of patients with Dravet syndrome and their prevalence of early death. Key Findings: Responses to the survey were collected from 91 hospitals, and a total of 63 of 623 patients with Dravet syndrome died. Data from 59 of these patients were analyzed. The patients’ ages at death ranged from 13 months to 24 years and 11 months, with a median age of 6 years and 8 months. The analysis showed that the risk of mortality remained high up to approximately 12 years of age. The causes of mortality included sudden death in 31 patients (53%), acute encephalopathy with status epilepticus (SE) in 21 patients (36%), drowning in 6 patients (10%), and acute hepatopathy in one patient (1%). The incidence of sudden death reached a first peak at 1–3 years of age and reached a second peak at 18 years and older. In contrast, the incidence of acute encephalopathy with SE reached a sharp peak at 6 years of age. Seven of 10 patients who underwent an SCN1A mutation analysis exhibited positive mutations without a specific mutation site. Significance: In the present study, the prevalence of Dravet syndrome–related mortality was 10.1%. The incidence of sudden death and acute encephalopathy with SE was the highest in infancy (1–3 years) and at early school ages (with a peak at 6 years), respectively. After approximately 12 years of age, the risk of mortality declined sharply. Neither the treatment nor the number of seizures was associated with any cause of mortality. In addition, it is difficult to predict which factors lead to a fatal outcome.